954239-22-6 Usage
General Description
6-(Trifluoromethyl)-1H-indazole is a chemical compound with the molecular formula C8H5F3N2. It is a derivative of indazole, a heterocyclic aromatic organic compound. The trifluoromethyl group in this compound is known for its electron-withdrawing properties, which can affect the reactivity and physical properties of the molecule. 6-(TRIFLUOROMETHYL)-1H-INDAZOLE has potential applications in pharmaceutical and agrochemical industries, as well as in materials science and organic synthesis. Like other fluorinated organic compounds, 6-(trifluoromethyl)-1H-indazole may also exhibit unique properties and behavior due to the presence of fluorine atoms, making it of interest for further study and potential use in various industrial and research settings.
Check Digit Verification of cas no
The CAS Registry Mumber 954239-22-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,4,2,3 and 9 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 954239-22:
(8*9)+(7*5)+(6*4)+(5*2)+(4*3)+(3*9)+(2*2)+(1*2)=186
186 % 10 = 6
So 954239-22-6 is a valid CAS Registry Number.
954239-22-6Relevant articles and documents
A novel copper-catalyzed, hydrazine-free synthesis of N-1 unsubstituted 1H-indazoles using stable guanylhydrazone salts as substrates
Rekowski, Szymon P.,Kroener, Bettina K.,Kathuria, Deepika,Wani, Aabid A.,Chourasiya, Sumit S.,Conrad, Jürgen,Bharatam, Prasad V.,Frey, Wolfgang,Beifuss, Uwe
, (2021/06/12)
A CuI-catalyzed, hydrazine-free transformation of 2-(2-bromoarylidene)guanylhydrazone hydrochlorides using Cs2CO3 as a base and DMEDA as a ligand at 120 °C for 5 h delivers substituted 1H-indazoles with yields up to 75%. The C,N double bond configuration of the substrates was determined by NMR experiments and quantum chemical calculations. The reaction mechanism was studied using quantum chemical calculations.
a-AMINO ACID DERIVATIVE AND PHARMACEUTICAL COMPRISING THE SAME AS ACTIVE INGREDIENT
-
Page/Page column 46, (2009/04/23)
The present invention provides novel α-amino acid derivatives of formula (1): (wherein, R1, R2, R3, R4, X and Y are as defined in the claims) or pharmaceutically acceptable salts, prodrugs or solvates thereof. T
